Background {#Sec1}
==========

Metastasis to the gallbladder is rare and in most cases is found incidentally on autopsy \[[@CR1], [@CR2]\]. The rarity and clinical similarity of metastasis to the gallbladder to benign or other malignant gallbladder diseases make a correct diagnosis difficult in clinical practice.

Cancers of the kidney account for 4% of all newly diagnosed malignancies in men and 3% in women, and in most cases they are renal cell carcinomas (RCCs) \[[@CR3]\]. Approximately one-third of patients with RCC already have metastases at the time of diagnosis, frequently to vascular-rich organs such as the lung, bone, and liver. Patients with distant metastases from RCC have a poor prognosis with a prospect of surviving for 5 years of \< 10% \[[@CR4]\]. However, curative resection of metastases in selected patients may improve long-term survival \[[@CR5]\]. In patients with a solitary metastasis, a 35--50% prospect of surviving for 5 years after complete metastasectomy has been reported \[[@CR4], [@CR6]\].

We report a rare case of a patient with gallbladder metastasis from RCC diagnosed 15 years after primary cancer excision, and review the previously reported 38 cases. We discuss the condition's presentation, surgical treatment, and survival outcomes. We also indicated the characteristics of preoperative image findings of gallbladder metastasis of RCC, which are considered to be helpful for the preoperative differential diagnosis of gallbladder tumors. It was thought to be clinically important that resection could allow long-term survival for patients with metachronous and localized RCC recurrences.

Case presentation {#Sec2}
=================

A 75-year-old Japanese (Asian) woman underwent a right nephrectomy for RCC approximately 15 years ago. Our patient did not present symptoms at admission, and her past medical, social, family, and environmental history was not appreciable. Her occupation was home manager, and she was on no medication prior to diagnosis. She did not smoke and consume alcohol, and her temperature was 36.3 °C, her blood pressure was 122/82 mmHg, and her pulse was 68 per minute. Laboratory findings at admission are shown below. Her white blood cell count was 3800 × 10^3/^μL, red blood cell count 414 × 10^4^/μL, hemoglobin 13.0 g/dL, hematocrit 39.1%, platelets 19.6 × 104/μL, total bilirubin 0.7 mg/dL, direct bilirubin 0.2 mg/dL, aspartate transaminase 23 IU/L, alanine transaminase 9 IU/L, total protein 7.3 g/dL, albumin 4.5 g/dL, lactate dehydrogenase 188 IU/L, γ-glutamyltransferase 11 IU/L, alkaline phosphatase 201 IU/L, amylase 129 IU/L, blood urea nitrogen 13.6 mg/dL, creatinine 0.64 mg/dL, sodium 137 mEq/L, potassium 3.9 mEq/L, chlorine mEq/L, C-reactive protein 0.03 mg/dL, carcinoembryonic antigen 1.5 ng/mL, carbohydrate antigen 19--94 U/mL, urinalysis pH 7.0, no uric protein, no urinary sugar, no ketone body, no uric blood, no bilirubin, and no white blood cell. No microbial examination was performed.

The tumor was 9.1 × 7.8 cm in diameter and confined to the capsule of the kidney. Pulmonary lobectomy was performed for left lung metastasis 11 years after the primary resection and an additional lung partial resection was performed for the metachronous left lung metastasis 14 years after the primary resection.

Examinations including whole body computed tomography (CT) before each surgery demonstrated no evidence of distant metastasis. A surveillance follow-up CT scan revealed a gallbladder lesion. No symptoms suggested cholecystitis, and the only biochemical abnormality was a slight elevation in levels of aspartate transaminase and alanine transaminase. Ultrasonography (US) showed a mass at the gallbladder fundus. Its surface was smooth, and the inner echo was slightly high and homogenous (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Ultrasonography shows an iso- to hyperechoic polyp at the fundus of the gallbladder (*yellow bar* indicates 10 mm)

A contrast-enhanced CT scan showed a 12-mm polypoid mass with high attenuation, enlarged from 4 mm 2 years ago (Fig. [2a, b](#Fig2){ref-type="fig"}). It had significantly high intensity in the arterial phase. On the coronal reconstruction image, attenuation was inhomogeneous in the mass and relatively higher on the wall side (Fig. [2c, d](#Fig2){ref-type="fig"}). There was no significant accumulation of contrast agent in any organ other than the gallbladder.Fig. 2A computed tomography scan shows tumor growth from 4 mm to 12 mm over a span of 2 years (**a** 2 years prior, **b** present). A contrast-enhanced computed tomography scan shows high intensity of the tumor during the arterial phase (**d** *yellow arrow*) in comparison with plain computed tomography (**c** *yellow arrow*)

Based on these image findings and the patient's medical history, we initially thought the gallbladder mass was a malignant tumor such as a gallbladder carcinoma. The possibility that the tumor was metastatic cancer remained, and we therefore performed open approach cholecystectomy to confirm the diagnosis and perform adequate treatment.

The isolated specimen showed a pedunculated tumor in the fundus of the gallbladder, and the surface of the tumor appeared black as a result of bleeding (Fig. [3a](#Fig3){ref-type="fig"}). Microscopically, we observed prominent vascular proliferation in the stalk and basal part of the tumor (Fig. [3b](#Fig3){ref-type="fig"}). The tumor was hypercellular and composed of clear cells arranged in funicular or alveolar growth with vascular interstitial tissue (Fig. [3c](#Fig3){ref-type="fig"}). The surface of the tumor was covered by epithelium, and extensive hemorrhage was observed under the surface (Fig. [3b](#Fig3){ref-type="fig"}). These histopathologic characteristics coincided with those of the renal tumor resected 15 years earlier (Fig. [3d, e](#Fig3){ref-type="fig"}).Fig. 3The surgical specimen shows a *black* pedunculated tumor in the fundus of the gallbladder (**a** *white arrow*). Pathological examination of hematoxylin and eosin staining shows tumor cells with clear cellular cytoplasm growth (**b** ×20, **c** ×200), and it is similar to the features of the renal primary tumor (**d** ×20, **e** ×200)

We performed immunohistochemical staining for vimentin and cytokeratin 7 (CK7). The tumor stained strongly for vimentin, but staining for CK7 was almost negative (Fig. [4](#Fig4){ref-type="fig"}), although for CK7, we observed a partially nonspecific immune reaction due to use of an automated immunostainer. These pathological features were similar to those of the renal primary tumor. Therefore, we diagnosed the gallbladder tumor as a metastasis from renal cell carcinoma. Our patient's postoperative course was uneventful and she was discharged at postoperative day 5. She is alive and recurrence free 3 years after cholecystectomy.Fig. 4Immunohistochemistry staining for vimentin shows that the tumor cells stain strongly but the gallbladder epithelium is negative. CK7 immunohistochemical staining also shows that the tumor cells barely stain, but the gallbladder epithelium stains strongly

Discussion {#Sec3}
==========

This report showed a rare case of a patient who underwent open simple cholecystectomy and presented gallbladder metastasis from RCC. Even when compared with previous literature, the period from primary resection to gallbladder metastasis was relatively long. This observation shows that patients with metachronous and localized recurrences of RCC could be expected to achieve long-term survival following resection.

Distant metastases of RCC discovered during autopsy are found mostly in the lungs, liver, bones, and contralateral kidney. Metastasis to the gallbladder is very rare and is found in only 0.4--0.58% of autopsy cases due to RCC \[[@CR2]\].

Malignant melanomas are the most common cause of metastatic tumors of the gallbladder in Western countries, and metastases from lung, renal, pancreatic, and colorectal cancers to the gallbladder have also been reported \[[@CR2], [@CR7]\]. To date, only 38 cases of RCC metastasizing to the gallbladder have been reported. Furthermore, there have only been seven cases, including this one, in which the metastasis was diagnosed 10 or more years after surgical resection of the RCC \[[@CR3], [@CR8]--[@CR13]\]. In all these cases, the histological type was clear cell carcinoma.

On previous report,  the processes of metastasis to the gallbladder was grouped into two types, direct invasion of the tumor and invasion of the tumor into the capillaries, stating that the latter process is comparatively rare \[[@CR2]\]. Gallbladder metastases occurred simultaneously in half of the cases and recurred metachronously in the other half. Another characteristic of these cases is the wide time range: 12 months to 27 years between the resection of the primary tumor and the reappearance of the tumor cells.

Dynamic contrast-enhanced CT is useful in the differential diagnosis of a metastatic gallbladder tumor from RCC and a primary gallbladder carcinoma, because the former is hypervascular \[[@CR14], [@CR15]\]. In the case we describe, contrast-enhanced CT showed the mass had high density on an arterial enhanced phase image. Another characteristic of these cases is the appearance of an echo-bright area on the surface of the tumor, indicating a submucosal tumor on US \[[@CR16]\].

Only two reports have described the use of positron emission tomography (PET)/CT scans to differentiate gallbladder metastasis from RCC \[[@CR2], [@CR16]\]. Kawahara and colleagues documented a tumor mass on the gallbladder wall on PET/CT images without high accumulation of fluorodeoxyglucose (FDG) \[[@CR2]\]. The role of PET/CT in gallbladder metastasis from RCC remains undefined.

Although RCC has some typical imaging characteristics, it remains extremely difficult to distinguish cases of primary and metastatic gallbladder carcinoma. In cases of RCC in which a gallbladder mass is observed simultaneously or metachronously, the possibility of gallbladder metastasis should be taken into account, although it is difficult to arrive at a preoperative diagnosis of gallbladder metastasis.

In the present patient, the gallbladder tumor was polypoid and over 10 mm in size. Furthermore, contrast-enhanced CT showed a high density on an arterial phase imaging. We thought it might be a gallbladder polyp or a malignant lesion, so we performed simple cholecystectomy for diagnosis and treatment since no suspicious findings of tumor invasion into the muscle layer of the gallbladder on preoperative imaging or intraoperative findings were noted.

Kavolius *et al.* have reported single organ metastasis and recurrence-free survival as prognostic factors after resection of metachronous metastatic lesions \[[@CR5]\]. Chung *et al.* reported eight cases of patients with isolated gallbladder metastasis recurrence-free survival (observed median 1.1 years, range from 0.1 to 6 years) in a cohort study of 33 renal cell carcinoma cases \[[@CR9]\], and they thought that isolated gallbladder single metastasis was an indication for surgery.

Although extended cholecystectomy is the standard operation when there is a strong suspicion of primary gallbladder cancer, it is important to excise metastatic lesions of RCC to the gallbladder. In Table [1](#Tab1){ref-type="table"}, nine cases of simple cholecystectomy, including laparoscopic surgery, for an isolated metastasis to the gallbladder resulted in cancer-free survival in all cases (including the present case). Therefore, if there is no obvious invasion of the gallbladder bed, a simple resection including laparoscopic surgery is expected to be curative.Table 1Previously reported cases of metastatic renal cell carcinoma of the gallbladder. Permission was granted by Ishizawa T., Okuda J., Kawanishi T. et al. © Asian Surgical Association and published by Elsevier B.V. 2006 to reuse this tableAuthorAge/SexMode of metastasisSyn or MetaInterval from primary cancerOther site of metaOp procedureMacroscopic findingsSize (cm)OutcomeYear of sourceSaito (present case)75/FSolitaryMeta15 yLungSCPedunculated1.2×0.92 y alive2018Botting \[[@CR18]\]66/MSolitaryMeta1 y 7 m(-)SCPolypoid4.2×2ND1963Terashima \[[@CR19]\]61/MMultipleSyn(-)BoneECMass2×22 m death1990Satoh *et al.* \[[@CR7]\]71/MSolitarySyn(-)PancreasECMushroom-shaped4×2.51 y 7 m alive1991Fullarton \[[@CR20]\]43/FMultipleSyn(-)Pancreas, kidneySCMass35 m died from cancer1991Golbey \[[@CR21]\]84/MSolitaryMeta13y(-)SCPedunculated3.5ND1991Nagler \[[@CR22]\]82/MSolitaryMeta5y(-)ECPolypoid3×3ND1994Pagano \[[@CR23]\]62/MSolitarySyn(-)LungSCRound mass3.5disease free1995King \[[@CR24]\]64/MSolitarySyn(-)(-)SCPolypodunclear2 y 2 m disease free1995Fujii \[[@CR25]\]69/MMultipleSyn(-)Adrenal glandECPolypoid2.8×2.53 m disease free1995Coskun \[[@CR26]\]52/MMultipleSyn(-)boneSCPolypoid3.5×2.5ND1995Lombardo \[[@CR27]\]77/MSolitaryMeta5 y(-)ECPolypoid3×3ND1996Kamimoto \[[@CR28]\]53/MMultipleMeta4 y(-)LCPolypoid1.56 m alive1996Sparwasser \[[@CR29]\]46/MSolitaryMeta3 y 8 m(-) Lung resectedSCPolypoid2.7×2.14 y4 m died from cancer1997Furukawa *et al.* \[[@CR14]\]41/MMultipleSyn(-)Lung, chest wallSCPedunculated1.9×1.3ND1997Uchiyama \[[@CR30]\]64/MMultipleMeta3 yKidneySCPedunculated1.9×1.17 m alive1997Celebi \[[@CR31]\]73/MSolitarySyn(-)LungECMushroom-shaped2.8×21 m died from other disease1998Ueki \[[@CR32]\]69/FSolitarySyn(-)(-)ECPedunculated1.67 m disease free2001Gekiya \[[@CR33]\]68/MSolitaryMeta15 y(-)SCPolypoidND1 y disease free2002Aoki \[[@CR34]\]63/MSolitaryMeta27 y(-)SCPedunculated7.5×36 y disease free2002Aoki \[[@CR34]\]80/MSolitaryMeta8 yLungSCPedunculated4.5×2.52 y disease free2002Miyagi \[[@CR35]\]53/MSolitaryMeta10 y 6 m(-)LCPolypoid2.5×1.5ND2003Limani \[[@CR36]\]64/MSolitaryMeta1 y(-)LCMassNDND2003Ishizawa *et al*. \[[@CR15]\]73/MSolitaryMeta5 y(-)SCPedunculated3.5×22 y disease free2006Hellenthal \[[@CR37]\]39/MSolitarySyn(-)(-)SCPolypoidND2 y 6 m alive2007Ricci \[9\]72/FSolitaryMeta16 yPancreasLCMassNDND2008Nojima \[[@CR38]\]61/MSolitarySyn(-)(-)SCPolypoid1.510 m alive2008Sand \[[@CR39]\]48/FSolitaryMeta5 yPancreas, kidneySCNDND2 m alive2009Patel *et al*. \[[@CR1]\]64/FSolitaryMeta6 y(-)LCPolypoid3ND2009Kawahara *et al*. \[[@CR2]\]73/FSolitarySyn(-)LungSCPolypoid1.0×0.8ND2010Shoji *et al*. \[[@CR8]\]50/MMultipleMeta3 yAdrenal grandSCPolypoid1.1×0.98 m alive2010Fang *et al*. \[[@CR13]\]45/MSolitaryMeta1 yLungSCPolypoid1.9×1.02 y 4 m death2010Fang *et al*. \[[@CR13]\]65/FSolitaryMeta1 yPsoas muscleSCPolypoid2.5×2.57 m death2010Fang *et al*. \[[@CR13]\]54/MSolitaryMeta7 y(-)SCPolypoid1.5×1.02 y 3 m alive2010Fang *et al*. \[[@CR13]\]51/MSolitaryMeta6 yKidneySCPolypoid1.7×0.83 y 1 m alive2010Decoene *et al*. \[[@CR10]\]47/FSolitaryMeta16 yBone, ovaryLCPolypoid1.9ND2011Jain and Chopra \[[@CR12]\]49/FSolitaryMeta6 y(-)SCPolypoid1.45×1.0ND2013Ueda *et al*. \[[@CR3]\]43/MSolitaryMeta1 y(-)ECPedunculated2.6ND2015*Abbreviations*: *Syn* synchronous metastasis, *Meta* metachronous metastasis, *SC* simple cholecystectomy, *ND* not determined, *EC* extended cholecystectomy, *LC* laparoscopic cholecystectomy

For an adequate follow-up and informed decisions about adjuvant immunotherapy with interleukin-2 and interferon alpha after cholecystectomy, gallbladder metastasis of RCC should be differentiated from primary clear cell carcinoma of the gallbladder through histochemical examination. Immunohistochemically, primary clear cell carcinoma of the gallbladder is strongly positive for CK7 but negative for vimentin, and metastatic RCC of the gallbladder is positive for vimentin but negative for CK7 \[[@CR17]\]. Based on the immunohistochemical findings, our final diagnosis was metastatic gallbladder tumor from RCC as opposed to primary clear cell carcinoma of the gallbladder.

The follow-up information on the previously reported cases is not sufficient to demonstrate the curability of cholecystectomy for a metastasis of RCC, since late recurrence is not uncommon with RCC. However, nine patients were reported to be cancer free with the longest follow-up interval of 6 years after cholecystectomy, and eight of these had a solitary metastasis. These reports suggest a favorable prognosis after cholecystectomy, particularly in patients with a solitary metastasis. Even for multiple metastases of RCC, cholecystectomy may be advocated, because the survival rates after curative resection of second and third metastases have not been found to be different from those after a first metastectomy \[[@CR5]\].

Conclusions {#Sec4}
===========

In conclusion, we describe a rare case of gallbladder metastasis from RCC diagnosed 15 years after primary cancer resection. In patients with a history of RCC, observation of a vascular-rich polypoid lesion of the gallbladder should raise the possibility of metastasis. Cholecystectomy may result in favorable long-term survival of patients with RCC metastases to the gallbladder.
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